|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-4-11
|
|
pubmed:abstractText |
Approximately 30% of renal cell carcinomas (RCCs) present as metastatic disease. Molecular markers have the potential to characterize accurately the biological behavior of tumors and they may be useful for determining prognosis.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1496-501
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15821467-Adult,
pubmed-meshheading:15821467-Aged,
pubmed-meshheading:15821467-Carcinoma, Renal Cell,
pubmed-meshheading:15821467-Female,
pubmed-meshheading:15821467-Humans,
pubmed-meshheading:15821467-Kidney Neoplasms,
pubmed-meshheading:15821467-Male,
pubmed-meshheading:15821467-Middle Aged,
pubmed-meshheading:15821467-Prognosis,
pubmed-meshheading:15821467-Survival Rate,
pubmed-meshheading:15821467-Tumor Markers, Biological
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
